Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.65 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | FAAH | O00519 | 2/20 | 0.57 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.56 |
| ▸ | PPARG | P37231 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8586140 | 1.00 | FFAR4 (0.65) | FFAR4FFAR1L3MBTL1FAAHGPR84 | |
| SCHEMBL15153576 | 1.00 | FFAR4 (0.65) | FFAR4FFAR1L3MBTL1FAAHGPR84 | |
| SCHEMBL13219941 | 1.00 | FFAR4 (0.65) | FFAR4FFAR1L3MBTL1FAAHGPR84 | |
| SCHEMBL16845300 | 1.00 | FFAR4 (0.65) | FFAR4FFAR1L3MBTL1FAAHGPR84 | |
| SCHEMBL8620968 | 1.00 | FFAR4 (0.65) | FFAR4FFAR1L3MBTL1FAAHGPR84 | |
| SCHEMBL15216442 | 1.00 | FFAR4 (0.65) | FFAR4FFAR1L3MBTL1FAAHGPR84 | |
| SCHEMBL18823717 | 1.00 | FFAR4 (0.65) | FFAR4FFAR1L3MBTL1FAAHGPR84 | |
| SCHEMBL15083800 | 1.00 | FFAR4 (0.65) | FFAR4FFAR1L3MBTL1FAAHGPR84 | |
| SCHEMBL8814461 | 1.00 | FFAR4 (0.65) | FFAR4FFAR1L3MBTL1FAAHGPR84 | |
| SCHEMBL2399703 | 1.00 | FFAR4 (0.65) | FFAR4FFAR1L3MBTL1FAAHGPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 770 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118852581-B | Modified IPDI curing agent, preparation method and application thereof | 万华化学集团股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| US-20250325970-A1 | CATALYST FOR POLYESTER DEPOLYMERIZATION OR CYCLIC ESTER SYNTHESIS, PREPARATION METHOD THEREFOR AND USE THEREOF | UNIV SICHUAN (CN) | 2025-10-23 | — | — | US | claimed |
| CN-120118346-A | High-melting-point heavy calcium carbonate filling master batch and preparation method thereof | 江西广源新材料有限公司 | 2025-06-10 | — | — | CN | claimed |
| CN-120079256-A | Asymmetric PMP hollow fiber oxygenation membrane and preparation method and application thereof | 杭州费尔新材料有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-120079257-A | Asymmetric PMP hollow fiber membrane for blood oxygenation and preparation method and application thereof | 杭州费尔新材料有限公司 | 2025-06-03 | — | — | CN | claimed |
| US-12281278-B2 | Thermal management fluids with synergistic heat capacity | ExxonMobil Technology and Engineering Company (US) | 2025-04-22 | — | — | US | claimed |
| EP-4527872-A1 | CATALYST FOR POLYESTER DEPOLYMERIZATION OR CYCLIC ESTER SYNTHESIS, PREPARATION METHOD THEREFOR AND USE THEREOF | Sichuan University (CN) | 2025-03-26 | — | — | EP | claimed |
| CN-119350547-A | Auxiliary agent for secondary battery, positive electrode slurry, positive electrode sheet and secondary battery | 深圳好电科技有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-119120116-A | Synthetic lanolin and preparation method thereof | 世名(苏州)新材料研究院有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-114733366-B | Preparation method of asymmetric hollow fiber membrane | 杭州费尔新材料有限公司 | 2024-08-20 | — | — | CN | claimed |
| WO-1998027950-A1 | ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-02 | — | — | WO | claimed |
| WO-1998027951-A2 | ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS SUBSTANTIALLY FREE OF SELECT POLAR SOLVENTS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-02 | — | — | WO | claimed |
| US-5750096-A | SOLID NON-POLYMERIC GELLANT BASED ON 12-HYDROXYSTEARIC ACID; ANHYDROUS LIQUID CARRIER | THE PROCTER & GAMBLE COMPANY (US) | 1998-05-12 | — | — | US | claimed |
| US-5744130-A | COMPRISING ACTIVE MATERIAL, NONPOLYMERIC GELLANT, ANHYDROUS LIQUID CARRIER; LOW RESIDUE | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-28 | — | — | US | claimed |
| US-5603925-A | CONTAINING POLYAMIDE GELATION AGENT | THE MENNEN COMPANY (US) | 1997-02-18 | — | — | US | claimed |
| US-5591424-A | Antiperspirant gel stick compositions | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-07 | — | — | US | claimed |
| WO-1996032924-A2 | ANTIPERSPIRANT COMPOSITION AND MANUFACTURING METHOD | COLGATE-PALMOLIVE COMPANY (US) | 1996-10-24 | — | — | WO | claimed |
| US-5429816-A | Hydroxystearic acid and n-acyl-glutamic acid as gellants | PROCTER & GAMBLE (US) | 1995-07-04 | — | — | US | claimed |
| US-4879054-A | LITHIUM 12-HYDROXYSTEARATE, POLY-ALPHA-OLEFIN, ALIPHATIC DIESTER, EXTREME PRESSURE ANTIWEAR ADDITIVES, SALT FORMATION | AMOCO CORPORATION (US) | 1989-11-07 | — | — | US | claimed |
| US-4840837-A | HEAT SOFTENABLE INK IN WAX | PILOT MAN-NEN-HITSU KABUSHIKI KAISHA (JP) | 1989-06-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250325970-A1 | CATALYST FOR POLYESTER DEPOLYMERIZATION OR CYCLIC ESTER SYNTHESIS, PREPARATION METHOD THEREFOR AND USE THEREOF | NOTUM, WEE1, FAR1 | FFAR4 74/4885FFAR1 138/4885L3MBTL1 4401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.